{
  "source_id": "eeo",
  "url": "https://www.eeo.com.cn/2026/0622/924295.shtml",
  "url_hash": "92a14c144dc9472e",
  "title": "Tvardi Therapeutics推进TTI-101肝癌二期试验 存战略合作可能",
  "content": "业务进展情况：\n由于TTI-101针对的是重要的STAT3靶点，公司被市场视为大型制药公司潜在的收购或合作目标\n。任何相关传闻或官宣都将成为重大事件。",
  "author": "经济观察网",
  "source_name": null,
  "publish_time": "2026-06-22T05:17:00",
  "publish_time_raw": "2026-06-22 05:17",
  "extracted_at": "2026-06-22T08:08:44.481254",
  "images": [],
  "word_count": 57
}